| 英文别名 |
17-Desethynyl Norethindrone Diacetate;[(8R,9S,10R,13S,14S,17S)-17-acetyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;17-Hydroxy-19-nor-17;A)-17-(Acetyloxy)-19-norpregn-4-ene-3,20-dione;A-pregn-4-ene-3,20-dione Acetate;UNII-2FM4UHU5ZG;(17alpha)-17-(Acetyloxy)-19-norpregn-4-ene-3,20-dione;DTXSID00451932;SCHEMBL10951986;19-Norpregn-4-ene-3,20-dione, 17-(acetyloxy)-, (17alpha)-;(17.ALPHA.)-17-(ACETYLOXY)-19-NORPREGN-4-ENE-3,20-DIONE;19-NOR-17.ALPHA.-PREGN-4-ENE-3,20-DIONE, 17-HYDROXY-, ACETATE;66964-58-7;19-Nor-17alpha-pregn-4-ene-3,20-dione, 17-hydroxy-, acetate;Norethisterone acetate impurity E [EP];19-NORPREGN-4-ENE-3,20-DIONE, 17-(ACETYLOXY)-, (17.ALPHA.)-;NORETHISTERONE ACETATE IMPURITY E [EP IMPURITY];2FM4UHU5ZG;19-Norpregn-4-ene-3,20-dione, 17-(acetyloxy)-, (17a)- (9CI); 19-Nor-17a-pregn-4-ene-3,20-dione, 17-hydroxy-, acetate (6CI,7CI); 3,20-Dioxo-19-nor-17a-pregn-4-en-17-yl acetate; 17-Desethynyl Norethindrone Diacetate; Norethisterone Acetate Imp. E (EP);17-Hydroxy-19-nor-17alpha-pregn-4-ene-3,20-dione Acetate |
